Designer drugs: Review and implications for emergency management.

MedStar author(s):
Citation: Human & Experimental Toxicology. 37(1):94-101, 2018 Jan.PMID: 28764574Institution: MedStar Washington Hospital CenterDepartment: Emergency MedicineForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Designer Drugs/ae [Adverse Effects] | *Drug Overdose/dt [Drug Therapy] | Emergencies | HumansYear: 2018ISSN:
  • 0960-3271
Name of journal: Human & experimental toxicologyAbstract: In the past 10 years, "designer drugs" such as synthetic cannabinoids and cathinones have emerged and come into widespread use, resulting in more overdose cases involving these new drugs in the United States. Emergency departments regularly treat a diverse array of drug intoxications, and providers must be cognizant of novel drugs of abuse and the associated clinical presentations in order to provide the most appropriate care. This review aims to describe the epidemiology, mechanism of action, clinical presentation, and treatment of intoxication for both the common and newest drugs of abuse.All authors: Chistov S, Li A, Mazer-Amirshahi M, Park M, Pourmand AFiscal year: FY2018Digital Object Identifier: Date added to catalog: 2017-08-04
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 28764574 Available 28764574

In the past 10 years, "designer drugs" such as synthetic cannabinoids and cathinones have emerged and come into widespread use, resulting in more overdose cases involving these new drugs in the United States. Emergency departments regularly treat a diverse array of drug intoxications, and providers must be cognizant of novel drugs of abuse and the associated clinical presentations in order to provide the most appropriate care. This review aims to describe the epidemiology, mechanism of action, clinical presentation, and treatment of intoxication for both the common and newest drugs of abuse.

English

Powered by Koha